Trial Profile
Canada Global HARMONY: Prospective, Multi-site, Study to Evaluate Subject Satisfaction With Facial Appearance Overall and the Aesthetic and Psychosocial Impact of Combined Facial Treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2021
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Deoxycholic acid (Primary)
- Indications Facial wrinkles; Glabellar lines
- Focus Therapeutic Use
- Acronyms HARMONY
- Sponsors AbbVie; Allergan
- 18 Nov 2020 Status changed from active, no longer recruiting to completed.
- 04 Feb 2020 Status changed from recruiting to active, no longer recruiting.
- 02 Apr 2019 Planned End Date changed from 30 Jun 2020 to 30 Aug 2020.